市場調査レポート

商品コード

1458165

デジタルPCRの世界市場規模、シェア、成長分析：技術別、製品タイプ別、用途別 - 産業予測（2024～2031年）

Global Digital PCR Market Size, Share, Growth Analysis, By Technology(droplet digital PCR and chip-based digital PCR ), By Product Type, By Application - Industry Forecast 2024-2031

出版日: 2024年03月25日 | 発行: SkyQuest

| ページ情報: 英文 219 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 832,842円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 974,268円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,115,694円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界のデジタルPCRの市場規模は、2022年に59億5,000万米ドルとなり、予測期間（2024～2031年）のCAGRは9.14%で、2023年の64億9,000万米ドルから、2031年までに130億7,000万米ドルに成長する見込みです。

世界のデジタルPCR（ポリメラーゼ連鎖反応）市場は、正確な核酸定量と分析に対する需要の高まりにより急成長を遂げています。デジタルPCRは、その比類のない精度と感度で知られ、遺伝子検査、疾病診断、および高度な分子診断ソリューションを提供することを目的とした研究活動において重要なツールとして機能しています。主な促進要因は、個別化医療とゲノム研究の進歩に対する需要の急増と並んで、遺伝性疾患と感染症の有病率の上昇です。しかしながら、デジタルPCR装置の高価格やエンドユーザーの限られた認識といった課題が、市場拡大の妨げとなっています。注目すべき動向は、デジタルPCRと次世代シーケンサー技術の統合や、様々なターゲットを同時に検出するためのマルチプレックスデジタルPCRアッセイの開発です。障害にもかかわらず、新興経済国における採用の増加、腫瘍学や感染症診断におけるアプリケーションの拡大、機能を強化した革新的な製品のイントロダクションから、大きな拡大機会が生じています。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主な投資の分析
主な成功要因
競合の程度

市場力学と見通し

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

デジタルPCRの世界市場：技術別

市場概要
ドロップレットデジタルPCR（ddPCR）・チップベースデジタルPCR（cdPCR）

デジタルPCRの世界市場：製品タイプ別

市場概要
機器
試薬・消耗品
ソフトウェア・サービス

デジタルPCRの世界市場：用途別

市場概要
臨床診断
研究
科学捜査
環境モニタリング画像

デジタルPCRの世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主な市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

Thermo Fisher Scientific（US）
Bio-Rad Laboratories（US）
QIAGEN（Germany）
F. Hoffmann-La Roche Ltd（Switzerland）
Fluidigm Corporation（US）
Merck KGaA（Germany）
Agilent Technologies（US）
BioMA（C）rieux SA（France）
Takara Bio Inc.（Japan）
Danaher Corporation（US）
JN Medsys（Singapore）
RainDance Technologies（US）
Formulatrix, Inc.（US）
Stilla Technologies（France）
Becton, Dickinson and Company（US）
Analytik Jena AG（Germany）
Douglas Scientific（US）
Sysmex Corporation（Japan）
GenMark Diagnostics, Inc.（US）
Quantabio（US）

Product Code: SQMIG35G2206

Global Digital PCR Market size was valued at USD 5.95 Billion in 2022 and is poised to grow from USD 6.49 Billion in 2023 to USD 13.07 Billion by 2031, at a CAGR of 9.14% during the forecast period (2024-2031).

The Global Digital PCR (Polymerase Chain Reaction) Market is experiencing rapid growth due to rising demand for precise nucleic acid quantification and analysis. Digital PCR, known for its unmatched accuracy and sensitivity, serves as a vital tool in genetic testing, disease diagnosis, and research endeavors, aiming to provide advanced molecular diagnostic solutions. Key drivers include the escalating prevalence of genetic disorders and infectious diseases, alongside a surge in demand for personalized medicine and genomic research advancements. Nonetheless, challenges such as the high cost of digital PCR instruments and limited end-user awareness hinder market progression. Noteworthy trends involve the integration of digital PCR with next-generation sequencing technologies and the development of multiplex digital PCR assays for simultaneous detection of various targets. Despite obstacles, significant expansion opportunities arise from increased adoption in emerging economies, widening applications in oncology and infectious disease diagnostics, and the introduction of innovative products with enhanced features.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital PCR Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital PCR Market Segmental Analysis

Global Digital PCR Market is segmented on the basis of technology, product type, application, and region. By technology, the market is segmented into droplet digital PCR (ddPCR) and chip-based digital PCR (cdPCR). By product type, the market is segmented into instruments, reagents and consumables, and software and services. By application, the market is segmented into clinical diagnostics, research, forensics, and environmental monitoring. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Digital PCR Market

The significant growth of the market for digital polymerase chain reaction (dPCR) is being propelled by remarkable technological advancements. This evolution from traditional PCR techniques enables direct quantification and clonal amplification of nucleic acids, meeting the rising demand for more precise and efficient diagnostic tools. With a surge in research and development efforts, diverse PCR technologies are emerging, presenting substantial advantages and driving further innovation in the field.

Restraints in the Global Digital PCR Market

The widespread uptake of digital PCR technology might encounter obstacles due to the substantial initial expenses linked with acquiring instruments and reagents. Digital PCR platforms demand specialized equipment and consumables, which could pose a financial challenge for research labs or smaller healthcare institutions. Such high expenditures might restrict the availability of digital PCR technology, especially in resource-constrained environments or for researchers facing budgetary limitations.

Market Trends of the Global Digital PCR Market

The integration of digital PCR and NGS technologies offers a comprehensive approach to genomic analysis, as they complement each other effectively. By combining digital PCR's precise quantification with NGS's sequencing capabilities, researchers can acquire both qualitative and quantitative genomic insights. This integrated approach enables the detection of rare genetic variants, validation of NGS findings, and thorough analysis of intricate genomic changes associated with various diseases.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Digital PCR Market by Technology

Market Overview
droplet digital PCR (ddPCR) and chip-based digital PCR (cdPCR)

Global Digital PCR Market by Product Type

Market Overview
instruments
reagents and consumables
and software and services

Global Digital PCR Market by Application

Market Overview
clinical diagnostics
research
forensics
and environmental monitoring Image

Global Digital PCR Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMA(C)rieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JN Medsys (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RainDance Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Formulatrix, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stilla Technologies (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Analytik Jena AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Douglas Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenMark Diagnostics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quantabio (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments